Mismatch Repair Deficiency

• Mismatch Repair Deficiency is a genetic condition where the body’s DNA repair system is faulty.
• It leads to an accumulation of genetic mutations over time.
• MMR Deficiency itself does not have direct symptoms, but its primary consequence is a significantly increased risk of developing certain cancers.
• It can be inherited (e.g., Lynch syndrome) or acquired during a person’s lifetime.
• Early detection and regular screening are crucial for individuals identified with MMR Deficiency due to the elevated cancer risk.

What is Mismatch Repair Deficiency?

Mismatch Repair Deficiency (MMR Deficiency) refers to a condition in which the cellular machinery responsible for correcting errors during DNA replication is impaired. The mismatch repair (MMR) system is a crucial part of a cell’s quality control, ensuring the accuracy of genetic information as cells divide. When this system is deficient, incorrect base pairs or small insertions/deletions that arise during DNA synthesis are not properly fixed, leading to an increased rate of mutations.

These accumulated mutations can occur in various genes, including those that regulate cell growth and division. The MMR system involves several key proteins, primarily encoded by genes such as MLH1, MSH2, MSH6, and PMS2. Dysfunction in any of these genes can result in MMR Deficiency, making the genome unstable. According to the National Cancer Institute, MMR deficiency is found in about 15% of colorectal cancers and 20-30% of endometrial cancers, highlighting its significant role in cancer development.

Symptoms and Causes of Mismatch Repair Deficiency

The **causes of Mismatch Repair Deficiency** are primarily genetic. It can arise from two main sources: inherited (germline) mutations or acquired (somatic) mutations. Inherited MMR Deficiency is most commonly associated with Lynch syndrome, an autosomal dominant genetic condition where individuals inherit a non-functional copy of an MMR gene from a parent. This predisposition means every cell in their body carries one faulty MMR gene, and if the second copy also becomes mutated, the MMR system fails. Acquired MMR Deficiency, on the other hand, occurs when mutations in MMR genes happen spontaneously in somatic cells during a person’s lifetime, often due to environmental factors or aging, and are not passed down to offspring.

Regarding **mismatch repair deficiency symptoms**, it is important to note that MMR Deficiency itself does not typically present with direct symptoms. Instead, its presence is usually identified through genetic testing or tumor analysis, often after a person has developed cancer. The “symptoms” are therefore those of the associated conditions, primarily various cancers. Individuals with inherited MMR Deficiency (Lynch syndrome) are at a significantly higher risk of developing certain cancers at younger ages compared to the general population. These include:

• Colorectal cancer
• Endometrial cancer
• Ovarian cancer
• Gastric (stomach) cancer
• Small bowel cancer
• Urinary tract cancer
• Brain tumors
• Sebaceous adenomas (skin tumors)

The specific types and age of onset can vary depending on which MMR gene is affected and other genetic or lifestyle factors.

Mismatch Repair Deficiency and Cancer Risk

The profound link between **mismatch repair deficiency and cancer** is well-established. When the MMR system is deficient, the accumulation of unrepaired DNA errors leads to a state known as microsatellite instability (MSI). Microsatellites are short, repetitive DNA sequences, and their length is highly variable in MMR-deficient cells due to the inability to correct replication errors. This genomic instability drives the development and progression of cancer by allowing mutations to accumulate in critical genes that control cell growth, differentiation, and programmed cell death.

Individuals with inherited MMR Deficiency, such as those with Lynch syndrome, face a substantially elevated lifetime risk of developing several types of cancer. For instance, the lifetime risk of colorectal cancer for individuals with Lynch syndrome can be as high as 70-80%, significantly higher than the general population’s risk of about 4-5%. Similarly, the lifetime risk for endometrial cancer in women with Lynch syndrome can reach 40-60%. Due to this increased risk, guidelines recommend regular surveillance and screening for individuals identified with MMR Deficiency, including colonoscopies, endometrial biopsies, and other cancer-specific screenings, often starting at an earlier age than for the general population. This proactive approach aims to detect cancers at their earliest, most treatable stages.